Showing results (61-70 of 170) with videos related to

Sort By:
Pageof 17
Breast Cancer Research and Treatment|April 26, 2008
Cost-effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC)Sang Gyu Lee, Young Geon Jee, Hyun Chul Chung, et al.
International Journal of Nanomedicine|June 28, 2014
Accurate sequential detection of primary tumor and metastatic lymphatics using a temperature-induced phase transition nanoparticulate systemKeun Sang Oh, Ji Young Yhee, Dong-Eun Lee, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|March 9, 2011
A prognostic model to identify patients with advanced pancreas adenocarcinoma who could benefit from second-line chemotherapySeung Tae Kim, Yoon Ji Choi, Kyong Hwa Park, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 15, 2023
A dual-action niclosamide-based prodrug that targets cancer stem cells and inhibits TNBC metastasisJi Hyeon Kim, Soeun Park, Eunsun Jung, et al.
Pharmacological Reports : PR|June 25, 2024
A derivative of 3-(1,3-diarylallylidene)oxindoles inhibits dextran sulfate sodium-induced colitis in miceYoung-Jin Jeong, Hae-Ri Lee, Sun-Ae Park, et al.
Medical Oncology (Northwood, London, England)|February 18, 2011
The serum bone morphogenetic protein-2 level in non-small-cell lung cancer patientsYoon Ji Choi, Seung Tae Kim, Kyong Hwa Park, et al.
Biomaterials|September 16, 2022
A synchronized dual drug delivery molecule targeting cancer stem cells in tumor heterogeneity and metastasisJi Hyeon Kim, Jung Min Park, Eunsun Jung, et al.
Cancer Research and Treatment|October 30, 2015
Caveolin-1 Modulates Docetaxel-Induced Cell Death in Breast Cancer Cell Subtypes through Different MechanismsJinho Kang, Joo Hee Park, Hye Jin Lee, et al.
Chemotherapy|March 18, 2011
Epidermal growth factor receptor mutations as a prognostic factor in Korean patients with advanced lung adenocarcinoma who had not been treated with received epidermal growth factor receptor tyrosine kinase inhibitorsSeung Tae Kim, Yoon Ji Choi, Kyong Hwa Park, et al.
International Journal of Pharmaceutics|December 12, 2018
Pluronics: Intelligent building units for targeted cancer therapy and molecular imagingNisar Ul Khaliq, Dal Yong Park, Byeong Min Yun, et al.
Pageof 17